Premium
P1‐057: A MULTIPLE ASCENDING‐DOSE STUDY OF THE PHARMACOKINETICS AND SAFETY OF LY3154207, A CENTRALLY‐ACTING DOPAMINE D1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR (D1 PAM), IN HEALTHY SUBJECTS
Author(s) -
Biglan Kevin,
Svensson Kjell A.,
Wilbraham Darren,
Tsai Max,
Kielbasa William
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.082
Subject(s) - pharmacokinetics , tolerability , medicine , adverse effect , placebo , blood pressure , dosing , dopamine , crossover study , dopamine receptor , ambulatory blood pressure , pharmacology , anesthesia , alternative medicine , pathology